CR8324A - USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICINE TO TREAT OSTEOMELITIS AND / OR SEPTIC ARTHRITIS - Google Patents

USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICINE TO TREAT OSTEOMELITIS AND / OR SEPTIC ARTHRITIS

Info

Publication number
CR8324A
CR8324A CR8324A CR8324A CR8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A CR 8324 A CR8324 A CR 8324A
Authority
CR
Costa Rica
Prior art keywords
joint
infection
combination
infections
bone
Prior art date
Application number
CR8324A
Other languages
Spanish (es)
Inventor
Thomas Testa Raymond
Calhoun Jason
T Mader Jon
Original Assignee
Wyeth Corp
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Univ Texas filed Critical Wyeth Corp
Publication of CR8324A publication Critical patent/CR8324A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invencion esta dirigida a un metodo para el tratamiento de infecciones de hueso o medula osea, infeccion de la articulacion o infeccion de los tejidos circundantes a la articulacion por la administracion del antibiotico tigeciclina sola o en combinacion con un antibiotico de rifamicina. En una realizacion de preferencia, la infeccion de hueso o de medula osea causa osteomielitis. En otra realizacion, la infeccion articular o infeccion de los tejidos circundantes causa artritis septica. La invencion tambien esta dirigida a la fabricacion de un medicamento para el tratamiento de infecciones de hueso y/o medula osea, o infecciones articulares y/o infecciones en los tejidos circundantes a la articulacion con tigeciclina sola o en combinacion con rifampicina.The present invention is directed to a method for the treatment of bone or bone marrow infections, joint infection or infection of the tissues surrounding the joint by the administration of the antibiotic tigecycline alone or in combination with a rifamycin antibiotic. In a preferred embodiment, bone or bone marrow infection causes osteomyelitis. In another embodiment, joint infection or infection of surrounding tissues causes septic arthritis. The invention is also directed to the manufacture of a medicament for the treatment of bone and / or bone marrow infections, or joint infections and / or infections in the tissues surrounding the joint with tigecycline alone or in combination with rifampicin.

CR8324A 2003-09-05 2006-04-04 USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICINE TO TREAT OSTEOMELITIS AND / OR SEPTIC ARTHRITIS CR8324A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50047403P 2003-09-05 2003-09-05

Publications (1)

Publication Number Publication Date
CR8324A true CR8324A (en) 2008-08-26

Family

ID=40257280

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8324A CR8324A (en) 2003-09-05 2006-04-04 USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICINE TO TREAT OSTEOMELITIS AND / OR SEPTIC ARTHRITIS

Country Status (8)

Country Link
AR (1) AR045586A1 (en)
CR (1) CR8324A (en)
GT (1) GT200400176A (en)
MY (1) MY140519A (en)
PA (1) PA8611301A1 (en)
PE (1) PE20050946A1 (en)
TW (1) TW200518741A (en)
ZA (1) ZA200602769B (en)

Also Published As

Publication number Publication date
MY140519A (en) 2009-12-31
PE20050946A1 (en) 2005-11-25
ZA200602769B (en) 2007-09-26
AR045586A1 (en) 2005-11-02
TW200518741A (en) 2005-06-16
GT200400176A (en) 2005-10-03
PA8611301A1 (en) 2005-03-28

Similar Documents

Publication Publication Date Title
CO5690590A2 (en) USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICIN TO TREAT OSTEOMYELITIS AND / OR SEPTIC ARTHRITIS
ATE248616T1 (en) BIOABSORBABLE DRUG DELIVERY DEVICE
ECSP077182A (en) METHODS FOR TREATMENT OF ENDOBRONCHIAL INFECTIONS
CY1113264T1 (en) STRONTIUM COMBINATIONS FOR THE PREVENTION / TREATMENT OF cartilage and / or bone diseases
ECSP066805A (en) SILINAN COMPOUNDS AS INHIBITORS OF CYSTEINE PROTEASA
DOP2006000052A (en) LENGTH TIME UP TO THE PROGRESSION OF THE DISEASE OR SURVIVAL OF CANCER PATIENTS
AR037109A1 (en) USE OF FLIBANSERINE
GT200500113A (en) PIRIMIDINE DERIVATIVES TO TREAT ANOMALO CELLULAR GROWTH
ES2194784T3 (en) PROCEDURE AND DEVICE FOR THE TREATMENT OF BODIES AFTER FRACTURING.
DOP2001000233A (en) PHARMACEUTICAL COMPOUNDS
SV2004001417A (en) FAMILY COMPOSITIONS AND PROCEDURES FOR MANAGING SELECTIVE AGONISTS OF THE EP2 RECEIVER REF. PC10465
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
BR0309757A (en) 6-alkylidene bicyclic penenes as beta-lactamase inhibitors
ECSP045405A (en) PENEMS 6-RENT HETEROTRICICLIL AS INHIBITORS OF THE BETA LACTAMASA
ECSP034635A (en) USE OF COMPOUNDS OF 1-PHENYL-3-DIMETHYLAMOPROPANE FOR THE TREATMENT OF URINARY INCONTINENCE
CR8324A (en) USE OF TIGECICLINE ONLY OR IN COMBINATION WITH RIFAMPICINE TO TREAT OSTEOMELITIS AND / OR SEPTIC ARTHRITIS
CR9691A (en) INHIBITORS OF 6-ALQUILIDENO-PENEME B-LACTAMA BICICLICOS AND ANTIBIOTIC COMBINATION OF B-LACTAMA: AN ANTIBIOTIC OF SPECTRO
BR0307085A (en) Combination therapy for the treatment of bacterial infections
WO2003075654A3 (en) Treatment of surfaces populated by bacteria with a lucilia sericata extract
BR0208654A (en) Veterinary compositions comprising avermectin oxime and praziquantel derivatives
GT200600332A (en) INHIBITORS OF 6-ALQUILIDEN-PENEM BETA-LACTAMASA TRICYCLES AND COMBINATION OF ANTIBIOTICS OF B-LACTAMA: A WIDE SPECTRUM ANTIBIOTIC
ECSP034632A (en) USE OF 6-DIMETILAMINOMETIL-1-FENIL-CICLOHEXACO SUBSTITUTED COMPOUNDS IN URINARY INCONTINENCE THERAPY
GT199600072A (en) ZWITTERIONIC FORMS OF TROVAFLOXACIN.
DK1439840T3 (en) Antibacterial monobactam compounds and methods for their use
GT200100099A (en) HYGROMYCIN DERIVATIVES A.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)